MO HB1935

Health carriers offering health benefit plans in Missouri must provide coverage for human papillomavirus (HPV) screening at testing intervals recommended by the American College of Obstetricians and Gynecologists, effective January 1, 2011

HPV screening is defined as any laboratory test that specifically detects infection by one or more human papillomavirus agents and is approved by the federal Food and Drug Administration

Coverage for HPV screening cannot be subject to greater deductibles or co-payments than other similar health care services under the plan

Requirements do not apply to supplemental insurance policies, including life care contracts, accident-only policies, specified disease policies, hospital fixed daily benefit policies, Medicare supplement policies, long-term care policies, or short-term major medical policies of six months or less duration